psychedelics regulation

States are Missing Out on Psychedelics Regulation

In 2023, Oregon will have a regulated psilocybin market. Colorado voters will have a chance to vote on something similar this fall (although Initiative 58 would not take effect until 2024). Other than that, not a single other state has any form of psychedelic regulation in the works. Last week, an attempt to simply decriminalize

decriminalize psychedelics

California Won’t Decriminalize Psychedelics This Year

In 2021, California State Senator Scott Wiener introduced SB-519, a statewide psychedelics decriminalization bill. Senator Wiener didn’t have the support to push the bill all the way forward in 2021, so he gathered momentum for a 2022 vote. After a gutting by the California Assembly, the state won’t decriminalize psychedelics in 2022. I’ve regularly blogged on

dea psychedelics tryptamines

DEA Retreats on Five Psychedelic Compounds

Friday was a great day for psychedelics. More generally, Friday was a great day for science and medicine, the rule of law and rational inquiry. This is because the DEA backed down on its clumsy attempt to ban five more psychedelic substances (tryptamines), which it had moved to place on Schedule I of the federal

florida psychedelics

Florida Legislature May Need Psychedelics Advocate

Florida Rep. Michael Grieco’s decision not to seek a new legislative term could negatively impact efforts to advance the legal use of psychedelics in the Sunshine State. The representative has been the most vocal advocate for psychedelics reform in the Florida Legislature. In 2021, Grieco filed a bill (HB 549) that would have legalized the

psilocybin controlled substances act reschedule

A Strategy for Rescheduling Psilocybin

Public and scientific interest in psychedelics such as psilocybin and MDMA is expanding. Once off-limits because of federal prohibition, a trickle of research from the 1990s has grown into a stream. But despite increasing acceptance by the public, and commercial investment in psychedelic therapies, aging federal laws stem the flow of vital research. Psilocybin, a